On the evening of April 14th, Sun Yat-sen University Da’an Gene Co., Ltd. (hereinafter referred to as “Da’an Gene”, 002030) released a performance forecast. It is expected that the first quarter net profit will be 186 million -200 million, an increase of 558%- 608%. The reason is that due to the impact of the new coronavirus pneumonia epidemic, the market demand for new coronavirus (2019-nCoV) nucleic acid detection kits, nucleic acid detection instruments, and related consumables has increased significantly, which has had a positive impact on the company’s performance.
Daan Gene also stated in the announcement that during the reporting period, the company launched a full industrial chain platform of nucleic acid detection technology that was independently developed and fully implemented to start up sufficient production capacity to provide new Coronavirus nucleic acid detection products, to ensure market supply.
On February 2, Daan Gene disclosed that it had obtained a medical device registration certificate issued by the State Drug Administration. The name of the medical device is the new coronavirus (2019-nCoV) nucleic acid detection kit (fluorescence PCR method), and the registration certificate number is National Machinery Injection Standard 20203400063. It is valid from the date of approval until January 27, 2021.
The official website shows that Daan Gene, relying on the strong scientific research platform of Sun Yat-sen University, is dominated by molecular diagnostic technology and integrates the development, production and sales of clinical testing reagents and instruments And a biomedicine high-tech enterprise integrating clinical testing services of independent national chain medical laboratories. The company was listed on the Shenzhen Stock Exchange in August 2004 and became the first listed company in the university-run industry in Guangdong province.
On January 20, Daan Gene said on the Shenzhen Stock Exchange Interactive Answering Investor Questions that the company has now developed the 2019 new coronavirus (2019-nCoV) nucleic acid Detection kit (PCR-fluorescent probe method) (ORF1ab), 2019 new coronavirus (2019-nCoV) ORF1ab / N nucleic acid detection kit (PCR-fluorescent probe method).
On April 14, Daan Gene reported closing at 18.62 yuan, up 2.48%. Since January 2, 2020, Da’an Gene’s stock price has risen by 64.6%.